SNBL USA, a wholly-owned subsidiary of Shin Nippon Biomedical Laboratories, Ltd. is a contract research organization that helps biopharmaceutical companies around the world advance their drug and clinical development strategies. Currently, SNBL has operations in Japan, the United States, China, and Cambodia, and is headquartered in Tokyo, Japan. Some of SNBL’s specialized capabilities include safety assessment of biologics, cardiovascular, reproductive toxicology, respiratory, immunotoxicology and carcinogenicity. Innovation at SNBL has enabled it to provide clients with data that meet the highest standards of precision and quality.